According to Oncure Medical, the acquisition expands the company’s national network of radiation oncology centers to 36 centers in three states.
Deloitte Corporate Finance acted as exclusive financial adviser to Radiation Oncology Associates (ROA) in connection with this partnership.
David Chernow, president and CEO of Oncure, said: “With this key addition, Oncure takes a critical step to expand our national network of radiation therapy facilities and provide more patients with extraordinary care.”